跳至主要内容
临床试验/EUCTR2014-003010-93-NL
EUCTR2014-003010-93-NL进行中(未招募)不适用

Pharmacokinetic Profile of Ropivacaïne after Periarticular Local Infiltration Analgesia for Primary Total Knee Arthroplasty - LIAkin

Sint Maartenskliniek0 个研究点开始时间: 2014年10月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -age 50-80 years
  • -ASA physical health classification I – II
  • -Body Mass Index (BMI) < 40
  • -patient planned for a primary unilateral posterior-stabilized tri-compartmental cemented total knee replacement (Genesis II - PS) under unilateral spinal anesthesia with 2 mL hyperbaric bupivacaine 0.5%
  • -scheduled for fast-track protocol TKA
  • -haemoglobin (Hb) concentration = 7.5 mMol/L
  • -written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Placement of a surgical drain
  • -Contra-indications for spinal anesthesia
  • -Known hypersensitivity to amide-type local anesthetics
  • -Hepatic or renal insufficiency
  • -Use of fluvoxamine, ciprofloxacin, ketoconazole, erythromycin, clarithromycin, itraconazole, or rifampicin because of their effect on ropivacaine clearance.
  • -Any other reason which in the opinion of the investigator makes the patient unsuitable for participation in the study

研究者

相似试验

Study to descrive the processing of ropivacaine in... | 临床试验